1. Home
  2. PRSO vs IRIX Comparison

PRSO vs IRIX Comparison

Compare PRSO & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.69

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.89

Market Cap

16.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
IRIX
Founded
2008
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
16.0M
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
PRSO
IRIX
Price
$0.69
$0.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
321.7K
39.1K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
81.23
51.85
EPS
N/A
N/A
Revenue
$14,573,000.00
$41,593,000.00
Revenue This Year
$18.48
$3.07
Revenue Next Year
$53.57
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
5.99
N/A
52 Week Low
$0.68
$0.87
52 Week High
$2.37
$1.65

Technical Indicators

Market Signals
Indicator
PRSO
IRIX
Relative Strength Index (RSI) 33.54 22.00
Support Level N/A $0.88
Resistance Level $0.94 $1.18
Average True Range (ATR) 0.05 0.03
MACD -0.00 -0.02
Stochastic Oscillator 12.21 8.04

Price Performance

Historical Comparison
PRSO
IRIX

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: